Publication | Closed Access

5,3′-Dihydroxy-6,7,4′-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells

Tumor BiologyMedicineAntiangiogenesis EffectsCancer Cell BiologyCancer BiologyAnti-cancer AgentPharmacologyCell BiologyCancer Research